At Colorectal Cancer Canada, we are proud to launch a new national advocacy campaign through our Never Too Young (N2Y) initiative. Our mission is clear: we are urging provincial and territorial health ministries across the country to lower the colorectal cancer screening age from 50 to 45 for average-risk Canadians. ...
February 2024 For cancer survivors, chronic pain is a potential long-lasting side effect of cancer treatment that can negatively impact quality of life. It is one of the most common symptoms reported by people who are living with cancer or have completed treatment, with about 55% of people undergoing treatment ...
Canada’s Drug and Health Technology Agency (CADTH) Expert Review Committee (pERC) issued its initial recommendation last month to reimburse Lonsurf® (trifluridine-tipiracil) in combination with bevacizumab for the treatment of patients with metastatic colorectal cancer (mCRC) who have already received OR are not candidates for available therapies. These include: fluoropyrimidine (5-FU)-, ...
What Emotions Could you Experience During the Diagnosis and Treatment? There is a range of positive and negative emotions you could face during your diagnosis and treatment. These emotions could be joy, hopelessness, isolation and loneliness, sadness and depression, fear, anxiety, hope, bittersweet feelings, anger, stress, gratitude, and guilt (National ...
Without Cancer, dating can be overwhelming and daunting. Add cancer to the equation and it may feel more complex. It is possible to have fun with dating and enjoy connecting with others throughout the cancer process, but it may require a bit more planning. Keep reading for tips on dating ...
This study aims to investigate dostarlimab therapy in patients with locally advanced mismatch-repair deficient (dMMR) / microsatellite instability high (MSI-H) rectal cancer who have not received any previous treatment. Patients who achieve a complete clinical response (no detectable tumour remains)...
The use of ctDNA to determine benefit of adjuvant chemotherapy after surgery Findings from a recent study on the potential benefit of circulating tumour DNA (ctDNA) testing for patients with colorectal cancer (CRC) were presented at the 2024 American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium this January. Currently, ...
Author: Carly Fleming, Registered Psychotherapist, Everwell Counselling (everwellcounselling.ca) Stress is a reality for all of us. There is no way to get through life without dealing with stress. On the one hand, it is helpful to approach stress with acceptance in order to live with as much ease as possible. ...
October 2023 Colorectal cancer, the third most common cancer worldwide, can present differently depending on where it develops within the colon, which can have a significant impact on the progression of the disease, treatment response, and patient outcomes. This article explores new research studying these differences and their implications for ...
October 2023 Recent findings presented at United European Gastroenterology Week demonstrated that patients with precancerous colorectal tumours showed significant variations in their gut microbiome. The connection between the gut microbiome - the totality of microorganisms such as bacteria, fungi, and viruses that colonize the intestines - and precancerous tumours has ...
1 Westmount Square, Suite 1630
Westmount, QC H3Z 2P9
Canada
info@colorectalcancercanada.com
© Colorectal Cancer Canada All rights reserved
Charitable registration number 86657 2423 RR0001
